Proximal Humerus Fractures: Randomized Study Between Locking Nails and Locking Plates for Neer 2 and 3 Parts
Launched by UNIVERSITY OF SAO PAULO · Nov 7, 2013
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fracture with less than 21 days;
- • Fractures of the proximal humerus classified as 2 or 3 parts of Neer, with involvement of the humeral head and one of the tuberosities;
- • Fracture with unacceptable deviation for the non-surgical treatment, according to the criteria of Neer Neer: fractures with deviation greater than 45 ° or 1 cm for the fragment of the humeral head and fractures with a deviation of the tuberosity greater than 0.5 cm;
- • Closed fractures;
- Exclusion Criteria:
- * Characteristics of the fracture:
- • fracture between the greater tubercle and the smaller, independent of the deviation;
- • Isolated fracture of the greater or lesser tuberosity
- • 4-part fractures of Neer;
- • Fracture involving the articular surface of the humeral head;
- • Fracture-dislocation of the proximal humerus
- * Other criteria:
- • Neurological injuries in the affected limb;
- • previous surgery on the affected shoulder;
- • associated fractures in the affected limb;
- • pathologic fractures;
- • lesions of the rotator cuff tendons previously diagnosed;
- • Psychiatric illnesses or inability to understand preoperative questionnaires;
- • Active infection or previous infection on the shoulder;
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, Sp, Brazil
Patients applied
Trial Officials
Mauro EC Gracitelli, MD
Principal Investigator
University of Sao Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials